June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Crohn's disease and ulcerative colitis are idiopathic, chronic, relapsing, inflammatory conditions that are immunologically mediated. Although their exact etiologies remain uncertain, results from ...

Learn why white rice, mashed potatoes, fruits without the skin, and other low-fiber and low-residue foods are your best bet after a Crohn’s or ulcerative colitis flare-up.

Amelenodor is under clinical development by AbbVie and currently in Phase I for Crohn's Disease (Regional Enteritis).

Expert Rev Gastroenterol Hepatol. 2010;4(2):167-180. Expert Rev Gastroenterol Hepatol. 2010;4(2):167-180. © 2010 Expert Reviews Ltd. Cite this: What is the Optimal ...

Over the past two decades, large genetic studies have linked tens of thousands of DNA variants to thousands of human traits ...

For pediatric patients with Crohn disease, early anti-tumor necrosis factor-alpha (anti-TNFα) therapy is beneficial in ...

Crohn disease is a chronic condition characterised by intestinal inflammation and progressive bowel damage associated with impaired functioning. In rheumatoid arthritis, which shares some common ...

Researchers have made a major medical breakthrough by developing a vaccine against the crippling digestive illness Crohn's disease. More than 100,000 people in the UK are stricken by the condition ...

Crohn's disease and ulcerative colitis look set to be the new battlefields for anti-inflammatory biologics, and AbbVie has just claimed important territory ahead of its main rivals while it awaits ...

Fatigue in IBD 1 year after diagnosis does not appear to be less prevalent even when applying stricter definitions of disease ...

French biotech moves on with the late stage drug development, after publishing impressive clinical trial results of ABX464 for treatment of colitis and hinting its potential in Crohn’s disease.